Manufacturer record
Vidhyasha Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Vidhyasha Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between March 2022 and October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Vidhyasha Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rosuvastatin Tablets IP (ROZUTIN- 10) | VDT-23531Mfg 2023-06 · Exp 2025-05 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Oct 2024 |
| Carvedilol Tablets IP 6.25 mg (Carviv-6.5 TABLETS) | VDT-23931Mfg 2023-10 · Exp 2025-09 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Apr 2024 |
| Isotretinoin Capsules IP (VISOTIN-10 CAPSULES) | VPS-21407DMfg 2021-11 · Exp 2024-10 | AssayAssay | RDTL ChandigarhState lab | Mar 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.